CHANGES IN WIDEFIELD CHOROIDAL THICKNESS AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Anti-VEGF therapy for neovascular AMD led to extensively decreased choroidal thickness. In patients with PNV, a greater decrease in overall choroidal thickness appeared to be associated with more effective resolution of retinal fluid. Observation of widefield choroidal thickness may be important for the management of neovascular AMD.
Authors
- Sorako Wakugawa
- Naoya Imanaga
- Hideki Koizumi (ORCID: https://orcid.org/0000-0002-9610-4386)
- Nobuhiro Terao
- Yasunori Miyara
- Marina Maehira
- Choyu Kuroshima
Institutions
- University of the Ryukyus (JP)
- Institute for Conflict Research (GB)
Publication Details
- Journal
- Retina
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1097/iae.0000000000004651
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41